Table 1.
Demographics and characteristics of patients undergoing SARS-CoV-2 testing.
| COVID-19 negative | COVID-19 positive | P-value | |
|---|---|---|---|
| N | 996 | 998 | |
| Demographics | |||
| Age (in years) (SD) | 51.69 ± 0.59 | 54.50 ± 0.60 | 0.0009 |
| Female sex (%) | 611 (61.28%) | 519 (52.00%) | <0.0001 |
| BMI (kg/m2) (SD) | 30.51 ± 0.35 | 29.78 ± 0.44 | 0.57 |
| Race (%) | |||
| White | 661 (66.30%) | 575 (57.62%) | <0.0001 |
| Black | 192 (19.26%) | 273 (27.35%) | <0.0001 |
| Symptoms | |||
| Cough | 594 (72.26%) | 714 (83.22%) | <0.0001 |
| Fever | 367 (49.33%) | 529 (62.53%) | <0.0001 |
| Fatigue | 230 (43.15%) | 352 (53.82%) | 0.0003 |
| Shortness of breath | 376 (54.18%) | 392 (48.10%) | 0.0185 |
| Diarrhea | 133 (23.09%) | 203 (28.67%) | 0.0236 |
| Loss of appetite | 62 (13.87%) | 186 (30.94%) | <0.0001 |
| Vomiting | 56 (10.24%) | 47 (6.83%) | 0.0379 |
| Impaired sense of smell | 18 (1.81%) | 186 (18.69%) | <0.0001 |
| Sore throat | 262 (26.36%) | 225 (22.59%) | 0.0537 |
| Nasal congestion | 238 (23.94%) | 247 (24.80%) | 0.68 |
| Rhinorrhea | 172 (17.30%) | 145 (14.56%) | 0.098 |
| Loss of taste | 22 (2.21%) | 215 (21.59%) | <0.0001 |
| Comorbidities | |||
| Smoking | 420 (47.89%) | 326 (40.70%) | 0.0032 |
| COPD (emphysema) | 84 (11.41%) | 58 (7.31%) | 0.0062 |
| Asthma | 221 (28.44%) | 147 (18.19%) | <0.0001 |
| Diabetes | 202(25.96%) | 206 (25.46%) | 0.863 |
| Hypertension | 416 (51.23%) | 429 (52.00%) | 0.7668 |
| Coronary artery disease | 138 (18.25%) | 112 (14.11%) | 0.0265 |
| Heart failure | 115 (15.33%) | 96 (12.09%) | 0.0644 |
| Cancer | 149 (18.60%) | 117 (14.18%) | 0.0188 |
| Immunosuppressive treatment | 115 (14.67%) | 86 (10.45%) | 0.0127 |
| Chronic rhinosinusitis | 70 (7.05%) | 52 (5.22%) | 0.0932 |
| Sinus surgery | 17 (1.71%) | 17 (1.71%) | 1 |
Bolded text signifies P-values that are statistically significant.